Compare Oscar Health Inc (OSCR) vs Atlassian Corporation PLC (TEAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Atlassian Corporation PLC — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Atlassian Corporation PLC trades at $206.79 (market cap $51.53B). The key difference: Atlassian Corporation PLC is far larger — about 5× Oscar Health Inc's market cap, and Oscar Health Inc is more actively traded (4,123,394 versus 2,904,511). Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Atlassian Corporation PLC for 65 Days on average.
| OSCR | TEAM | |
|---|---|---|
Market Cap | $10.22B | $51.53B |
Volume | 4,123,394 | 2,904,511 |
Sector | Health | Technology |
52-Week High | $33.81 | $206.79 |
52-Week Low | $10.85 | $57.15 |
Typical Hold Time | 15 Days | 65 Days |
Enterprise Value | $6.57B | $51.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Atlassian (TEAM) trades at $203.57, up 4.04% on the day, with a bullish technical signal from moving averages and strong analyst support. Revenue growth is robust, reaching $5.22B in 2025, though the company remains unprofitable with a net income margin of -0.82%. Recent news highlights AI-driven product adoption and cloud momentum as key growth catalysts, with the stock rallying 180% since April 2026 according to Investor's Business Daily on 2026-09-18.
The outlook is positive due to AI integration and market expansion, but high valuation multiples (P/S of 8.06, EV/EBITDA of 242.85) and persistent losses pose risks. Analysts are overwhelmingly bullish with a 69.77% buy rating and a consensus price target of $191.16, though the current price exceeds this target, suggesting near-term caution amid long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Atlassian Corporation PLC
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →
